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Abstract
Introduction: Numerous cases of pneumonia caused by coronavirus disease 2019 (COVID-19) were reported in Wuhan, 
China. Chest computed tomography (CT) scan is highly important in the diagnosis and follow-up of lung disease 
treatment. The present meta-analysis was performed to evaluate chest CT scan findings in COVID-19 patients.
Material and methods: All research steps were taken according to the Meta-Analysis of Observational Studies In Epi-
demiology (MOOSE) protocol and the final report was based on Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines. We registered this review at the International Prospective Register of 
Systematic Reviews (PROSPERO, CRD42019127858).
Results: Forty eligible studies including 4598 patients with COVID-19 were used for meta-analysis. The rate of posi-
tive chest CT scan in patients with COVID-19 was 94.5% (95% CI: 91.7-96.3). Bilateral lung involvement, pure 
ground-glass opacity (GGO), mixed (GGO pulse consolidation or reticular), consolidation, reticular, and presence 
of nodule findings in chest CT scan of COVID-19 pneumonia patients were respectively estimated to be 79.1%  
(95% CI: 70.8-85.5), 64.9% (95% CI: 54.1-74.4), 49.2% (95% CI: 35.7-62.8), 30.3% (95% CI: 19.6-43.6), 17.0%  
(95% CI: 3.9-50.9) and 16.6% (95% CI: 13.6-20.2). The distribution of lung lesions in patients with COVID-19 pneu-
monia was peripheral (70.0% [95% CI: 57.8-79.9]), central (3.9% [95% CI: 1.4-10.6]), and peripheral and central 
(31.1% [95% CI: 19.5-45.8]). The pulmonary lobes most commonly involved were the right lower lobe (86.5% [95% CI: 
57.7-96.8]) and left lower lobe (81.0% [95% CI: 50.5-94.7]).
Conclusions: The most important outcomes in chest CT scan of patients with COVID-19 pneumonia were bilateral 
lung involvement, GGO or mixed (GGO pulse consolidation or reticular) patterns, thickened interlobular septa, 
vascular enlargement, air bronchogram sign, peripheral distribution, and left and right lower lobes involvement. 
Our study showed that chest CT scan has high sensitivity in the diagnosis of COVID-19, and may therefore serve as 
a standard method for diagnosis of COVID-19.
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Introduction
In December 2019, numerous cases of pneumonia of un-
known cause were reported in Wuhan, Hubei Province, 
China. On January 7, 2020, a novel coronavirus, severe 
acute respiratory syndrome coronavirus-2 (SARS-CoV-2), 
was identified as the causative organism by Chinese ex-
perts by performing real-time polymerase chain reaction 
(real-time PCR) on patients’ respiratory tract specimens. 
It was subsequently named 2019-nCoV by the World 
Health Organization (WHO) [1]. There is also evidence 
that it can be transmitted through respiratory droplets 
and contact with infected patients as well as fecal–oral 
transmission [2,3]. Etiologically speaking, virulence of 
a pathogen may increase sharply during host shifts [4,5], 
and in contrast, the virulence may decrease through pro-
longed host-parasite interactions [6]. 
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Coronavirus disease 2019 (COVID-19) is primarily 
transmitted through respiratory droplets and close con-
tact, and the incubation period is usually between 1 and 
14 days. The common symptoms include fever, dry cough, 
fatigue, and the gradual onset of shortness of breath. 
People who carry the virus are the source of infection, 
even during the incubation period. Early detection of the 
disease or the virus carrier is the key to prevent further 
spread. However, confirmation of the infection requires 
a nucleic acid detection kit. The virus can be identified in 
swabs, secretions, and sputum from the respiratory tract, 
blood, or feces [7]. 
Computed tomography (CT) scan is highly impor-
tant in the diagnosis and follow-up of lung disease treat-
ment. In a review of different studies, one may find that 
the imaging features of COVID-19 pneumonia are varied, 
from their natural appearance to diffuse changes in the 
lungs. In addition, different radiological patterns are ob-
served at different times over the course of the disease. 
Since the onset of symptoms and acute respiratory dis-
tress syndrome (ARDS) was short-lived in the first cases 
of COVID-19 pneumonia, early detection of the disease is 
essential for the management of these patients [8]. 
Numerous studies have been performed regarding the 
findings of CT scans in COVID-19 patients and the results 
are inconsistent [3,8-46]. According to previous studies, le-
sions in patients with COVID-19 show ground-glass opac-
ity (GGO) or mixed (GGO pulse consolidation or reticu-
lar) patterns, and are likely to have peripheral distribution, 
bilateral involvement, lower lobe dominance, and multi-
lobe distribution [8-15]. In a systematic review and meta-
analysis, a structured review of all documentation and their 
composition can provide a more comprehensive picture 
of all dimensions of the subject. One of the main goals of 
meta-analysis, which is a combination of different studies, 
is to reduce the differences between parameters by increas-
ing the number of studies involved in the analysis process. 
Another noteworthy goal of meta-analysis is to find in-
consistencies between the results and their causes [47-49]. 
The present meta-analysis was conducted to evaluate CT 
scan findings of COVID-19 at the time of admission.
Material and methods
Study protocol
The International Prospective Register of Systematic Re-
views (PROSPERO) database and international databases 
were first reviewed to find relevant published or ongoing 
projects. All research steps were taken according to the 
Meta-Analysis of Observational Studies in Epidemiology 
(MOOSE) protocol [49] and the final report was based on 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guideline (Suppl Table 1) [50]. 
Each stage of the study was conducted by two indepen-
dent authors. Disagreements were resolved by discussion 
or a third author was involved. We registered this review 
at PROSPERO (registration number: CRD42020178078) 
(Suppl Figure 1). Available at: https://www.crd.york.ac.uk/
prospero/display_record.php?RecordID=178078.
Literature search
We searched the Web of Science: ISI, Medline-Ovid, Sci-
ence Direct, Scopus, EMBASE, PubMed/Medline, Co-
chrane Library (Cochrane Database of Systematic Re-
views – CDSR), EBSCO, CINAHL and Google Scholar 
databases using the following keywords: “2019 nCoV”, 
“Novel coronavirus”,“COVID-19”, “Novel coronavirus 
2019”, “Wuhan pneumonia”, “Wuhan coronavirus”, “acute 
respiratory infection”, “COVID-19”, and “SARS-CoV-2”, 
“CT scan”, “Computed tomography”, “Radiology”, “Radio-
graphy”, “Clinical Characteristics”, “clinical features”, and 
“COVID-19”. An example of a combined search within 
PubMed is as follows: (“2019 nCoV”, OR “Novel corona-
virus”, OR “COVID-19”, OR “Novel coronavirus 2019”, 
OR “Wuhan pneumonia”, OR “Wuhan coronavirus”, OR 
“acute respiratory infection”, OR “COVID-19”, OR “SARS-
CoV-2”) AND (“CT scan” OR “Computed tomography” 
OR “Radiology” OR “Radiography” OR “Clinical charac-
teristics” OR “clinical features” OR “COVID-19”). 
The search was conducted on March 20, 2020. Addi-
tional studies were identified by reviewing the reference 
lists of relevant articles. No language restrictions were 
applied. Since the present study was based on a regular 
review of previous studies, approval of the organizational 
review board and patient satisfaction were not necessary. 
The research received no specific funding. Grey literature 
was found at medrxiv (https://www.medrxiv.org/) and 
manual search of related articles was also conducted.
Inclusion and exclusion criteria
Inclusion criteria were all cross-sectional epidemiologi-
cal studies aimed at examining chest CT scan findings 
in COVID-19 patients from January 1, 2020 until March 
20, 2020 without language restrictions. Exclusion criteria 
were as follows: 1. Non-random sampling; 2. Duplicate 
studies; 3. Studies on non-adult population (more than 
10% of sample size being children); 4. Being irrelevant; 
5. Sample size smaller than 10 participants; 6. Diagnostic 
intervention for COVID-19 other than laboratory confir-
mation; 7. CT scan findings have not been verified by at 
least one radiology expert; 8. Poor quality in qualitative 
evaluation; and 9. Case reports, review articles, and letters 
to the editor without quantitative data.
Study selection and data extraction
Two authors independently presented the results of the 
initial search with the title and abstract. At this stage, du-
plicate and unrelated studies were excluded. Duplicate 
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studies were identified manually or using EndNote X9. 
Both authors then reviewed the full text of appropriate ar-
ticles for the inclusion and exclusion criteria. Finally, the 
authors extracted the data independently from the articles. 
Any discrepancy between the data extractors was resolved 
by consensus or by a third author. It should be noted that 
when an article reported duplicate information from the 
same patients, both reports were combined to obtain the 
most complete data, but it was considered as one case.
The data summary form includes the following items: 
first author’s name and year of publication, country and 
province, article references, study design, mean age and stan-
dard deviation, average duration from onset of symptoms 
until admission, time of performing CT scan, COVID-19 
detection method, patient description, sample (respiratory 
secretions, blood, etc.), sample location (nasal, pharyngeal, 
etc.), number of patients (total, male and female), number 
of patients referred to the intensive care unit (ICU), qual-
ity of articles, outcomes information: positive chest CT scan 
in COVID-19 patients, including the sensitivity of chest 
CT, bilateral pneumonia, predominant chest CT scan pat-
terns [GGO, mixed (GGO pulse consolidation or reticular), 
consolidation, reticular, and presence of nodule], other chest 
CT scan features (thickened interlobular septa, vascular en-
largement, air bronchogram sign, bronchial wall thickening, 
bronchiolectasis, fibrous stripes, crazy-paving pattern, thick-
ening of the adjacent pleura, pleural effusion and lymphade-
nopathy), distribution of lesions (peripheral, central, and 
peripheral pulse central), lobes involvement (right upper 
lobe, right middle lobe, right lower lobe, left upper lobe, and 
left lower lobe) and number of involved lobes (one lobe, two 
lobes, three lobes, four lobes, and five lobes).
Qualitative evaluation
Based on the type of studies, the adapted Newcastle-Ottawa 
Scale (NOS) was used to evaluate the risk of bias [51]. Three 
categories were defined: studies with scores less than 6 were 
low-quality studies, studies with scores of 6 or 7 were me-
dium-quality, and studies with scores of 8 or 9 were high-
quality studies. 
Statistical analysis
The I2 index (with values ranging from 0 to 100%) was used 
to evaluate the heterogeneity between studies; values above 
75% indicate high heterogeneity, values within 50-74% 
indicate significant heterogeneity, values within 25-49% 
indicate moderate heterogeneity, and values below 25% 
indicate low heterogeneity [52,53]. In addition, p < 0.1 
was also defined for heterogeneity. Meta-analysis was 
performed with at least three studies. In the case of low 
heterogeneity the fixed effects model, and otherwise the 
random effects model, was used to combine the studies. 
Results were reported as pooled prevalence and 95% con-
fidence interval. To identify the cause of heterogeneity, we 
could not perform subgroup analysis or meta-regression 
due to limitations. Sensitivity analysis for meta-analyses 
with at least five studies was performed by omitting one 
study at a time to evaluate the consistency of the results. 
Funnel plots and the Begg and Egger tests were used to 
evaluate publication bias. All analyses were performed us-
ing comprehensive meta-analysis. P-values less than 0.05 
were considered statistically significant. 
Results
Description of included studies
We identified 2266 potential articles from databases. After 
removing duplicates, there were 766 articles left. After 
evaluating the titles and abstracts, 76 articles were remov-
ed for at least one of the following reasons: non-random 
sampling (n = 10), studies on non-adult population (n = 3), 
being irrelevant (n = 650), diagnostic intervention for 
COVID-19 other than laboratory confirmation (n = 3), 
CT scans findings not verified by at least one radiology ex-
pert (n = 2), poor quality in qualitative evaluation (n = 0), 
and case reports, review articles, and letters to the edi-
tor without quantitative data (n = 58). Finally, 40 eligible 
studies with 4598 patients with COVID-19 were used 
for meta-analysis. This process is illustrated in Figure 1. 
All studies were conducted in China and all of them were 
of good or moderate quality and the details of studies are 
summarized in Table 1. The mean age of the study partici-
pants was 50.52 years (95% CI: 50.87-52.17).
Risk of bias
The risk of bias based on the NOS tool is shown in Table 1. 
Fourteen and 26 studies had moderate and good quality, 
respectively.
Sensitivity of chest CT findings for COVID-19 
The sensitivity of chest CT scan in patients with COVID-19 
was 94.5% (95% CI: 91.7-96.3; I2 = 98.6%). The lowest and 
highest estimates were for studies by Haiyan et al. (61.5%) 
and many other studies (100%), respectively (Figure 1A).
Bilateral lung involvement 
Bilateral lung involvement in chest CT scan with COVID-19 
pneumonia was observed in 79.1% of patients (95% CI: 
70.8-85.5) (Figure 2B).
Predominant chest CT scan patterns
Pure GGO, mixed (GGO pulse consolidation or reticular), 
consolidation, reticular, and presence of nodule findings 
in chest CT scan of COVID-19 pneumonia patients were 
observed in 64.9% (95% CI: 54.1-74.4), 49.2% (95% CI: 
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(n = 650) 
Full-text articles
 assessed  
for eligibility 
(n = 116) 
Full-text articles excluded (n = 76),  
with reasons:  
- non-random sampling (n = 10), 
- studies on non-adult population (n = 3),
-  diagnostic intervention for COVID-19  
other than laboratory confirmation (n = 3), 
-  CT scans findings have not been verified  
by at least one radiology expert (n = 2),
- poor quality in qualitative evaluation (n = 0),
-  case reports, review articles, and letters to 
the editor without quantitative data (n = 58) 
Studies included  
in qualitative synthesis 





(n = 40) 
Figure 1. Preferred reporting items for systematic reviews and meta-anal-
yses flowchart
35.7-62.8), 30.3% (95% CI: 19.6-43.6), 17.0% (95% CI: 
3.9-50.9) and 16.6% (95% CI: 13.6-20.2) of patients (Fig-
ure 3).
Other chest CT scan features
Other chest CT scan features are shown in Figure 4: thick-
ened interlobular septa – 63.6% (95% CI: 52.1-73.8), vas-
cular enlargement – 61.4% (95% CI: 40.4-79.0), air bron-
chogram sign – 53.5% (95% CI: 40.3-66.2), bronchial wall 
thickening – 19.8% (95% CI: 12.6-29.6), bronchiolectasis 
– 19.9% (95% CI: 6.5-47.2), fibrous stripes – 17.2% (95% 
CI: 5.2-44.2), crazy-paving pattern – 21.7% (95% CI: 13.8-
32.5), thickening of the adjacent pleura – 30.0% (95% CI: 
16.1-48.8), pleural effusion – 6.9% (95% CI: 4.7-10.1) and 
lymphadenopathy – 4.7% (95% CI: 3.0-7.5) (Figure 4).
Lesions distribution
The distribution of lung lesions in patients with COVID-19 
pneumonia was as follows: peripheral (70.0% [95% CI: 
57.8-79.9]), central (3.9% [95% CI: 1.4-10.6]), and peri-
pheral and central (31.1% [95% CI: 19.5-45.8]) (Suppl 
Figure 1).
Lobes involvement
Pulmonary lobes involvement in patients with COVID-19 
pneumonia was as follows (Figure 5): right upper lobe 
(58.4% [95% CI: 33.6-79.5]), right middle lobe (49.7% 
[95% CI: 23.0-76.6]), right lower lobe (86.5% [95% CI: 
57.7-96.8]), left upper lobe (64.5% [95% CI: 37.3-84.7]), 
and left lower lobe (81.0% [95% CI: 50.5-94.7]).
Number of involved lobes 
In patients with COVID-19 pneumonia, the number of 
involved lobes was as follows (Suppl Figure 2): one lobe 
(58.4% [95% CI: 33.6-79.5]), two lobes (31.1% [95% CI: 
19.5-45.8]), three lobes (10.5% [95% CI: 8.0-13.8]), four 
lobes (20.1% [95% CI: 15.4-25.9]), and five lobes (43.2% 
[95% CI: 34.2-52.6]).
Sensitivity analysis
Sensitivity analysis was performed for all meta-analyses 
and it showed that the overall result remains robust after 
the omission of one study at a time (Suppl Figures 3-7).
Risk of publication bias 
Publication bias was evaluated for studies that showed 
positive chest CT scan of COVID-19 patients (Begg’s 
test = 0.774 and Egger’s test < 0.001) and for studies that 
showed bilateral lung involvement in chest CT scan of 
COVID-19 patients pneumonia (Begg’s test = 0.194 and 
Egger’s test < 0.001) (Suppl Figure 8).
Discussion
The present study is the first systematic review and meta-
analysis that extensively examines chest CT scan findings 
in COVID-19 patients. Our study showed that chest CT 
scan has high sensitivity in the diagnosis of COVID-19. 
COVID-19 is a new disease with serious consequences for 
public health. Chest CT scan is an important part of dis-
ease detection for patients suspected of having COVID-19 
infection and may help early detection of lung malforma-
tions for the purpose of screening highly suspected pa-
tients, especially those with negative initial reverse-tran-
scription polymerase chain reaction (RT-PCR) screening 
[54]. In fact, given the limited number of RT-PCR kits in 
many centers and the likelihood of false negative RT-PCR 
results, the National Health Commission of China has en-
couraged clinical findings and chest CT scan [55]. Our re-
view showed some imaging findings that are often seen in 
patients with COVID-19. The present study showed that 
94.5% of COVID-19 patients had positive chest CT scan 
findings, while the frequency of bilateral lung involve-
ment in chest CT scan of COVID-19 pneumonia patients 
was 79.1%. It is important to observe the high incidence 
of bilateral organizing pneumonia in these patients. This 
suggests that corticosteroids may be an option to suppress 
this immune response in lung parenchyma of COVID-19 
pneumonia.
 Chest CT scan in COVID-19
Figure 2. Meta-analysis of sensitivity of chest computed tomography scan (A) and meta-analysis of bilateral lung involvement in chest computed tomog-
raphy scan (B) in patients with COVID-19
A
B
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Figure 3. Meta-analysis of pure ground-glass opacity (GGO) (A), mixed (GGO pulse consolidation or reticular) (B), reticular (C), consolidation (D), and presence 
of nodule (E) findings in chest computed tomography scan of COVID-19 pneumonia
A
B
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Figure 4. Meta-analysis of thickened interlobular septa (A), vascular enlargement (B), air bronchogram sign (C), bronchial wall thickening (D), bronchiolec-
tasis (E), fibrous stripes (F), crazy-paving pattern (G), thickening of the adjacent pleura (H), pleural effusion (I) and lymphadenopathy (J) findings in chest 
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Figure 5. Meta-analysis of right upper lobe (A), right middle lobe (B), right lower lobe (C), left upper lobe (D), and left lower lobe (E) involvement in chest 
computed tomography scan of COVID-19 pneumonia
Viruses are a common cause of respiratory tract infec-
tion. Imaging findings of viral pneumonia are varied, and 
may overlap with other infectious and inflammatory lung 
diseases. Viruses in the same viral family have a similar 
pathogenesis, so chest CT scan may help identify distinct 
patterns and features in immunocompromised patients 
[56]. Meta-analysis of initial data suggests that chest CT 
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Figure 5. Cont.
lar to other viruses such as the middle east respiratory 
syndrome (MERS-CoV) and severe acute respiratory syn-
drome (SARS-CoV) [57].
In the present study, most pulmonary lesions include 
bilateral lung involvement with multiple lung lobes (pre-
dominantly right lower lobe and left lower lobe), with 
dominant distribution in the peripheral portion of the 
lungs. Studies have shown that influenza pneumonia tends 
to affect the lower lobes [56,58]. Wang et al. also showed 
that H7N9 pneumonia has a predominant distribution in 
the right lower lobe [58]. Both H1N1 and SARS pneumo-
nia are more peripherally distributed [59,60], whereas no 
lobe infection is found in H5N1 influenza [61]. However, 
lung involvement with peripheral predominance has also 
been observed in SARS and MERS. Similarly, previous 
coronavirus pneumonias have a similar pattern. The dom-
inant peripheral distribution for COVID-19 was shown 
in our study. Such a distribution is obvious at first glance. 
This feature of chest CT scan is caused by alveolar injury 
and pulmonary interstitial edema. We also observed some 
chest CT scan features of COVID-19 that differ from chest 
CT scan features of SARS and MERS. Unifocal involve-
ment is more common than multifocal involvement in 
patients with SARS and patients with MERS [62,63]. 
However, contrary to what is seen in the chest CT scan 
of patients with COVID-19, multi-lobe involvement was 
more common than single-lobe involvement in the pres-
ent meta-analysis. Thus, more than two lobes are likely to 
be involved in this disease. To the best of our knowledge, 
these findings have not been reported in the literature re-
lated to SARS and MERS.
Our results showed that the most common findings 
of imaging were pure GGO, GGO with mixed consolida-
tion or reticular pattern, interlobular septal thickening, 
and consolidation. Reticular and nodular pattern were 
relatively small, which may be explained in the first stage 
of the disease. In H7N9 pneumonia, most cases showed 
consolidation [62]. Each of the chest CT scan patterns in 
our patients is nonspecific and may overlap with other 
microorganism infections such as H7N9 pneumonia, 
D
E
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H1N1 virus infection, SARS, MERS, and avian influenza 
A (H5N1) [60-63].
GGO, consolidation, and interlobular septal thicken-
ing are the most common chest CT scan findings of H1N1 
influenza pneumonia, too [59]. Based on the present me-
ta-analysis, pure GGO is a common finding in about 65% 
of cases, and GGO with interlobular septal thickening/
consolidation in 49% of COVID-19 pneumonia patients. 
Thus, these features of chest CT scan can be seen in most 
patients. This finding, along with the dominant distribu-
tion in the peripheral part of the lungs, is not common in 
other viral pneumonias [8,18,27,29,60,61]. 
In addition, we found that all features of chest CT scan 
that exist in the initial chest CT scan of patients with CO-
VID-19, such as GGO and consolidation, and other chest 
CT scan features such as vascular enlargement, interlobu-
lar septal thickening, and air bronchogram sign, are also 
present in the chest CT scan of SARS and MERS. The low 
incidence of pleural effusion and lymphadenopathy noted 
in our data was also a feature of chest CT scan in previous 
studies about SARS [57]. This may be due to the inherent 
anatomical features of the lower lobe bronchus. The right 
lower lobe bronchus is tighter than other bronchi of the 
lung, and the angle between the right lower lobe and the 
long axis of the trachea is smaller, so it is more viral at 
early stages. Most likely, it attacks the bronchial branches 
of the lower lobe and causes infection.
Interestingly enough, we found that most patients have 
vascular enlargement lesions (61.4%) that may be caused 
by an acute inflammatory response. However, vascular 
changes are not similar to changes in malignant lesions 
such as lung adenocarcinoma that cause vascular dilatation 
or irregularity and vascular convergence, which may be 
due to chronic progression and tumor infiltration [17,64].
Angiotensin II converting enzyme is a key molecule 
involved in the development and progression of acute 
lung failure. COVID-19 induces direct lung injury by in-
volving angiotensin converting enzyme, which contrib-
utes to the progression of alveolar injury [65]. This may 
explain the pathological mechanism of GGO and consoli-
dation as well as rapid changes in chest CT scan findings. 
Our results support the observed process, according to 
which bilateral GGOs or mixed GGOs in chest CT scan 
should prompt the radiologist to recommend COVID-19 
as a possible diagnosis [66,67].
Conclusions
In summary, this work is a meta-analysis on preliminary 
studies of chest CT scan findings about COVID-19, aimed 
at introducing the common imaging manifestations of the 
disease. Radiologists play an important role in rapid iden-
tification and early detection of new cases, which can be 
useful not only for the patient but also for public health 
surveillance systems. It is important to recognize the fact 
that the appearance of CT findings about COVID-19 has 
some similarities to other viral diseases, especially those 
in the same viral family (SARS and MERS). Future stud-
ies are recommended to determine how CT scans of CO-
VID-19 patients change after treatment.
Limitations of this study include the following: 1. 
All studies were performed in China, and the severity of 
chest CT scan manifestations might be affected by ethnic 
factors; 2. Most patients were hospitalized patients and 
patients with milder symptoms or those who were not 
hospitalized, which may cause bias in the results; 3. In 
most preliminary studies, chest CT scan findings were 
not separately reviewed according to patients admitted to 
the ICU or the isolation ward; 4. Follow-up for chest CT 
scan during treatment until discharge was not included in 
our study; 5. Our results are based on CT findings during 
admission, but patients might have experienced symp-
toms before admission (because chest CT scan findings 
are influenced by the clinical course of the disease), and 
during this time the patient might have received antiviral 
or antibacterial drugs, or steroid therapy, and this might 
have affected the chest CT scan findings; 6. Since all 
studies were performed in 2020 in China with the same 
diagnostic method, we could not discover the cause of 
heterogeneity. 
In conclusion, the most important outcomes in chest 
CT scan of patients with COVID-19 pneumonia were 
bilateral lung involvement, GGO or mixed (GGO pulse 
consolidation or reticular) patterns, thickened interlobu-
lar septa, vascular enlargement, air bronchogram sign, 
peripheral distribution, left and right lower lobes involve-
ment, and one or five lobes involvement.
Our study showed that chest CT scan has high sensi-
tivity in diagnosis of COVID-19, and may therefore serve 
as a standard method for diagnosis of COVID-19. Rapid 
detection may lead to early control of the transmission. 
By diagnosing viral pneumonia on CT scan, infected or 
suspected patients can be isolated and treated in a timely 
manner to optimize patient management, especially for 
hospitals or communities without RT-PCR test kits. How-
ever, chest CT scan is still limited in terms of identifying 
specific viruses. It is important that radiologists recognize 
whether chest CT scan findings for COVID-19 overlap 
with chest CT scan findings for diseases caused by differ-
ent virus families, such as adenovirus. 
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